Multidrug-resistant Mycoplasma genitalium infections in Europe

J F Braam, L van Dommelen, C J M Henquet, J H B van de Bovenkamp, J G Kusters

Research output: Contribution to JournalArticleAcademicpeer-review


In Japan and Australia, multidrug-resistant Mycoplasma genitalium infections are reported with increasing frequency. Although macrolide-resistant M. genitalium strains are common in Europe and North America, fluoroquinolone-resistant strains are still exceptional. However, an increase of multidrug-resistant M. genitalium in Europe and America is to be expected. The aim of this paper is to increase awareness on the rising number of multidrug-resistant M. genitalium strains. Here, one of the first cases of infection with a genetically proven multidrug-resistant M. genitalium strain in Europe is described. The patient was a native Dutch 47-year-old male patient with urethritis. Mycoplasma genitalium was detected, but treatment failed with azithromycin, doxycycline and moxifloxacin. A urogenital sample was used to determine the sequence of the 23S rRNA, gyrA, gyrB and parC genes. The sample contained an A2059G single nucleotide polymorphism (SNP) in the 23S rRNA gene and an SNP in the parC gene, resulting in an amino acid change of Ser83 → Ile, explaining both azithromycin and moxifloxacin treatment failure. The SNPs associated with resistance were probably generated de novo, as a link with high-prevalence areas was not established. It is, thus, predictable that there is going to be an increase of multidrug-resistant M. genitalium strains in Europe. As treatment options for multidrug-resistant M. genitalium are limited, the treatment of M. genitalium infections needs to be carefully considered in order to limit the rapid increase of resistance to macrolides and fluoroquinolones.

Original languageEnglish
Pages (from-to)1565-1567
Number of pages3
JournalEuropean Journal of Clinical Microbiology and Infectious Diseases
Issue number9
Publication statusPublished - Sep 2017


  • Anti-Bacterial Agents/pharmacology
  • Drug Resistance, Multiple, Bacterial
  • Europe/epidemiology
  • Genes, Bacterial
  • Humans
  • Male
  • Middle Aged
  • Mycoplasma Infections/drug therapy
  • Mycoplasma genitalium/drug effects
  • Polymorphism, Single Nucleotide
  • Population Surveillance


Dive into the research topics of 'Multidrug-resistant Mycoplasma genitalium infections in Europe'. Together they form a unique fingerprint.

Cite this